European Archives - Page 215 of 1370 - European Medical Journal

MVA-BN Vaccine Offers Safe Mpox Protection in At-Risk Groups

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Dupilumab Linked to Increased Psoriasis Risk in Atopic Dermatitis

Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.

Widespread Ignorance of Alcohol’s Cancer Risk

Despite alcohol being a leading preventable cause of cancer in the United States, public awareness of its cancer risk remains strikingly low, according to a new study.

Critical Management of Neurocysticercosis with Hydrocephalus

Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…

Minimally Invasive Treatment for Benign Prostatic Hyperplasia

Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.

Purple briefcase on grey background

Sun Pharma appoints Richard Ascroft as North American CEO

Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.

Can Microbiome-Guided Therapy Improve Cystic Fibrosis Outcomes?

A new international trial has investigated the safety and efficacy of tailoring antibiotic treatment for cystic fibrosis exacerbations based on sputum microbiome analysis.

Combined Therapy for Allergic Rhinitis Shows Superior Results

The combination therapy demonstrated a significantly higher response rate (98.28%) compared to loratadine alone (87.93%).

Mitigating the Treatment Gap in Drug-Resistant Epilepsy

For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…

EMJ Neurology 13 [Supplement 7] 2025

Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE)…